000 01589nam  2200337zi 4500
0019.905137
003CaOODSP
00520230210153529
006m     o  d f      
007cr cn|||||||||
008211119s2021    onc     o    f000 0 eng d
020 |a9780660410173
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP2-4/2019E-1-PDF
24500|aCIPARS 2019 : |bexecutive summary : key findings.
264 1|a[Guelph, Ont.] : |bCanadian Integrated Program for Antimicrobial Resistance Surveillance = Programme intégré canadien de surveillance de la résistance aux antimicrobiens, |c[2021]
300 |a1 online resource (3 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Sommaire et faits saillants du PICRA pour 2019.
61020|aCanadian Integrated Program for Antimicrobial Resistance Surveillance.
650 0|aDrug resistance in microorganisms|zCanada.
650 0|aAnti-infective agents|zCanada.
7102 |aCanadian Integrated Program for Antimicrobial Resistance Surveillance, |eissuing body.
7102 |aPublic Health Agency of Canada, |eissuing body.
77508|tSommaire et faits saillants du PICRA pour 2019.|w(CaOODSP)9.905140
794 |tCanadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) 2020 : |w(CaOODSP)9.917447
795 |tCIPARS 2018 : |w9.884670
85640|qPDF|s830 KB|uhttps://publications.gc.ca/collections/collection_2021/aspc-phac/HP2-4-2019-1-eng.pdf